Comera Life Sciences Holdings, Inc. Total Liabilities and Equity
Comera Life Sciences Holdings, Inc. had Total Liabilities and Equity of $3.07 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2023-11-09
- 2023-09-30: Liabilities and Equity $3.07M.
- 2023-06-30: Liabilities and Equity $2.34M.
- 2023-03-31: Liabilities and Equity $3.00M.
- 2022-12-31: Liabilities and Equity $3.73M.
| Period end | Liabilities and Equity |
|---|---|
| 2023-09-30 | $3.07M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.34M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.00M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.73M 10-Q · filed 2023-11-09 |
| 2022-09-30 | $4.94M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.13M 10-Q · filed 2022-08-15 |
| 2021-12-31 | $7.42M 10-K · filed 2023-03-17 |
| 2020-12-31 | $545.88K 8-K · filed 2022-09-06 |